Institut Pasteur | 130 years of biomedical research on Mythryl: “Institut Pasteur researchers developed "optonanobody": a…”

Institut Pasteur | 130 years of biomedical research

Institut Pasteur researchers developed "optonanobody": a light-controlled nanobody targeting α7 nicotinic receptors. Switch receptors on/off with light, no genetic editing needed. New research tool for Alzheimer's, Parkinson's & schizophrenia. #Neuroscience ↘️ pubs.acs.org/doi/10.1021/...

pubs.acs.orgAn Optonanobody for Reversible Photoactivation of Recombinant and Native α7 Nicotinic ReceptorsPhotopharmacology, which enables the precise optical control of endogenous receptor activity, represents a powerful approach in neuroscience. However, photochromic diffusible ligands often exhibit lim...

24/7/26, 7:26 am4 reposts9 likes

Post